Literature DB >> 19541539

Drug resistance mechanisms in helminths: is it survival of the fittest?

Catherine E James1, Amanda L Hudson, Mary W Davey.   

Abstract

Development of resistance to anthelmintic drugs is an increasing problem that decreases the productivity of livestock and threatens the success of treatment in humans. It is essential to understand the mechanisms in the development of resistance so that alternative treatment strategies can be developed. Changes in genes or in gene expression in response to drugs enable the organism to survive treatment and might reflect evolution in a toxic environment in which drug resistance leads to 'survival of the fittest'. Here, we review knowledge of resistance mechanisms, focusing on changes in drugs (identified by single-nucleotide polymorphisms), the involvement of transport proteins and drug efflux that prevent the drug from reaching the target, and the role of detoxification mechanisms that modify the drug.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541539     DOI: 10.1016/j.pt.2009.04.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  54 in total

1.  Molecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme.

Authors:  Ajay Kumar Rana; Sharat Chandra; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

2.  Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel.

Authors:  Ravi S Kasinathan; William M Morgan; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2010-05-12       Impact factor: 1.759

3.  Derquantel and abamectin: effects and interactions on isolated tissues of Ascaris suum.

Authors:  Sreekanth Puttachary; Sasa M Trailovic; Alan P Robertson; David P Thompson; Debra J Woods; Richard J Martin
Journal:  Mol Biochem Parasitol       Date:  2013-03-21       Impact factor: 1.759

4.  On the mode of action of emodepside: slow effects on membrane potential and voltage-activated currents in Ascaris suum.

Authors:  S K Buxton; C Neveu; C L Charvet; A P Robertson; R J Martin
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.

Authors:  J Utzinger; G Raso; S Brooker; D De Savigny; M Tanner; N Ornbjerg; B H Singer; E K N'goran
Journal:  Parasitology       Date:  2009-11       Impact factor: 3.234

Review 6.  Current drug targets for helminthic diseases.

Authors:  Ajay Kumar Rana; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2013-03-26       Impact factor: 2.289

7.  Target selected treatment with levamisole to control the development of anthelmintic resistance in a sheep flock.

Authors:  Ana Carolina de Souza Chagas; Luciana Ferreira Domingues; Yousmel Alemán Gaínza; Waldomiro Barioni-Júnior; Sérgio Novita Esteves; Simone Cristina Méo Niciura
Journal:  Parasitol Res       Date:  2015-11-28       Impact factor: 2.289

8.  Landscape genetics reveals focal transmission of a human macroparasite.

Authors:  Charles D Criscione; Joel D Anderson; Dan Sudimack; Janardan Subedi; Ram P Upadhayay; Bharat Jha; Kimberly D Williams; Sarah Williams-Blangero; Timothy J C Anderson
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

9.  A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility.

Authors:  Michael J Smout; Andrew C Kotze; James S McCarthy; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

Review 10.  ABC multidrug transporters in schistosomes and other parasitic flatworms.

Authors:  Robert M Greenberg
Journal:  Parasitol Int       Date:  2013-03-06       Impact factor: 2.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.